All In MedTech

FDA Clearance Tracker · P010032-S217

SCS EPG 2-Port Header (Model 3042)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 22, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 22, 2024

Approved

Time to decision

205 days

Received May 1, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P010032-S217
Device name
SCS EPG 2-Port Header (Model 3042)
Applicant location
Plano, TX
Received
May 1, 2024
Decided
Nov 22, 2024
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P010032

Device type

Device class
Class III

Every decision under product code LGW

FDA's approval statement

As written in FDA's record.

Approval for a new external pulse generator (EPG) header design (model 3042) and high-definition multimedia interface (HDMI) extension cable to be incorporated into the SCS EPG Invisible trial system, as well as removal of the SCS multi-lead trial cable (MLTC) (model 3013).

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.